The effect of halothane-induced profound systemic arterial hypotension on brain ischemia was evaluated by comparison with hypotension caused by oligemia and trimethaphan as well as nonhypotensive controls. Mean cerebral tissue lactate concentrations after halothane-induced hypotension at 5, 30, and 60 minutes were 4.34, 5.92, and 7.48 mM/kg. There was no significant difference between halothane and control animals during the experimental period. At 30 and 60 minutes, both oligemic and trimethaphan groups were higher than the control and halothane series. Definite protection from cerebral ischemia is provided by halothane during induced hypotension. Exact mechanisms of protection conveyed by halothane are unclear, but are probably not related to relative increased blood flow since cerebral vasodilation is maximal in these low blood-pressure ranges irrespective of etiology.
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brain metabolism halothane anesthesia lactate brain ischemia hypotension cerebral I NDUCED profound arterial hypotension is an intraoperative adjunct for reduction of hemorrhage in the treatment of select vascular lesions. While preservation of cerebral cellular substrates and enzymes with certain inhalational anesthetics has been demonstrated during normotensive anesthesia, a,4,23 glycolytic processes have been incompletely studied during profound hypotension. 24 Although normotensive anesthesia provides a certain degree of safety during ischemia, induced systemic hypotension itself may adversely alter somatic oxidative processes. 24 In the investigation of cerebral tissue lactate concentration (CTL) as a measure of cellular conversion from aerobic to anerobic metabolism during oligemic hypotension and trimethaphan-induced hypotension, the latter was found to provide minimal protection from severe cerebral ischemia compared to oligemia. 9,14
Since halothane is frequently used for intraoperative hypotension, this study was undertaken to determine whether halothane provides protection from cerebral ischemia in a comparable experimental situation.
Material and Methods
Eight healthy mongrel dogs (13 to 18 kg) were anesthetized intravenously with pento-Protection from cerebral ischemia by halothane hypotension barbital (30 mg/kg). A cuffed endotracheal tube was passed, and the animals were ventilated with ambient air at a tidal volume and rate that provided end-expiratory CO2 concentrations of 4.5% to 5.5%. A large bore polythelene cannula was positioned in the abdominal aorta via the femoral artery for recording of systolic, diastolic, and mean arterial pressures (MAP) on a Sanborn polygraph* via a Statham transducer.t Deep body temperature, monitored by esophageal thermistor, was maintained between 36.5 ~ and 37.5 ~ C by heating blankets. Control measurements of arterial pH, pO2, pCO2, lactate, and oxygen saturation were normal during preparation. Lead II of the electrocardiogram was monitored continuously.
Following a midline scalp incision with subperiosteal temporal muscle reflection and bilateral wide craniectomies, the dura was excised atraumatically without damage to the venous sinuses. The exposed cortex was frequently irrigated and covered with salineimpregnated cotton pledgets. After craniectomy and stabilization, the animals were anesthetized with halothane and compressed air via an in-line vaporizer, and semi-closed carbon dioxide absorption system. An MAP of 30 to 35 mm Hg served as initiating time for cerebral tissue removal. Ten minutes of halothane administration were generally necessary to reduce the MAP to experimental levels of 30 (---5) mm Hg which was maintained by increasing or reducing halothane flow. Four control dogs (Table 1) were treated identically except for hypotension.
At appropriate time intervals (see Resuits, and Tables 1, 2, 3 and 4) a 1-gm sample of brain tissue was removed by sharp excision and immersed in liquid nitrogen within 5 to 7 seconds. Samples were removed in regular sequence: the 5-minute specimen from the right parietooccipital cortex, the 30-minute specimen from the right frontal area, and the 60-minute sample from the left parietooccipital area. Samples Tissue was prepared for cerebral lactate assay using the method of Lowry, et al. 15 Each sample was placed intact and frozen into 6% weight per volume perchloric acid and homogenized in a preweighed glass homogenizer. The CTL analyses were performed on deproteinized neutralized aqueous extracts. Lactate in the aqueous extract was determined by a lactate dehydrogenase method." Spectrophotometric determination* of the conversion of nicotinamideadenine dinucleotide (NAD) to reduced NAD was used for the final measurement. 2 Blood lactate was analyzed by established techniques 25 in which the enzyme dehydrogenase catalyzes the oxidation of lactate to pyruvate by betadiphosphoridine nucleotide. Lactic acid was determined by measurement of the change in absorbance on spectrophotometry. A repeated measure mixed-model analysis of variance design (AOV) was employed for analysis of data. Significant F ratios were followed by one-way AOV; to detect differences between pairs of groups *Beckman DU-2 spectrophotometer manufactured by Beckman Instruments, Inc., 2500 Harbor Boulevard, Fullerton, California. the ratios were also analyzed by the Tukey multiple testing method) ~
Results
Tables 1, 2 and 3 summarize the results of the control, oligemic, and trimethaphan animal series respectively. It can be seen that hypotension with both oligemia and trimethaphan causes significant elevation in CTL after 30 minutes, indicating ischemia. This quantity of lactate accumulation can be likened to cerebral circulatory arrest with an associated poor prognosis? 4,3~ A comparison of oligemic hypotension and trimethaphan-induced hypotension data at 60 minutes suggests slight protection from ischemia conveyed by the latter agent (Fig.  1 ) . Control values for CTL in this laboratory determined by these types of experiments have been consistently established to range up to 6 mM/kg (Table 1 ) .
Mean CTL concentrations after halothane-induced hypotension at 5, 30, and 60 minutes were 4.34 (SE-+0.40), 5.92 (SE -+ 0.87), and 7.48 (SE-1.08) mM/kg (Table 4 and Fig. 1 ). For each time period, comparison of the four groups by AOV resulted in a significant F test (p < 0.01, p<0.001, p<0.001).
There was no significant difference between the halothane and control animals during the entire experimental period (p < 0.05) (Fig. 1) At 5 minutes in the oligemic group, the CTL was significantly higher than in the halothane and control animals (p <0.05). At 30 minutes it was higher in both the oligemic and trimethaphan groups than in the control (p<0.01) and halothane (p <0.01) groups. At 60 minutes, CTL concentrations were higher in both the oligemic and trimethaphan groups than in the control (p < 0.01, p < 0.01 ) and halothane (p < 0.01, p < 0.1) series, and were also greater in the oligemic as compared to the trimethaphan group (p < 0.05).
During induced hypotension and coincident with cerebral samples, aortic arterial blood was withdrawn and analyzed. Control values were generally normal, and blood gases approximated normal in all experiments. Slight variations were probably due to the stress of the hypotensive state. The blood lactate averaged 2.1 mM/1 (range, 0.4 to 4.1), the pCO2 averaged 36 mm Hg (range 22 to 50) and the 02 saturation averaged 94% (range 86 to 98).
Discussion
It is established that the concentration of cerebral tissue lactate (CTL) increases under ischemic conditions. 1~
Furthermore, previous reports demonstrate that arterial hypotension results in tissue lactate accumulation even without subnormal arterial 02 tension, 9'14'34 presumably because decreased perfusion provides inadequate substrate for metabolism 1~
and prevents "washout" of accumulated lactate, a,l~,z6 The accumulation of lactate in the brain thus most likely represents both an indication of the degree of cerebral hypoxia and the relative failure of tissue perfusion. While our data indicate that halothane provides protection of the central nervous system from ischemia during prolonged systemic hypotension, the exact mechanisms of preservation of aerobic glycolysis are unknown. It is presumed that there is no precapillary sphincteric spasm in the cerebral microcirculation of the type that accounts for hypoxia to somatic tissues during shock. 2s Rather, the mechanism for inadequate perfusion of cerebral tissue during both oligemic and trimethaphan hypotension is the inability of the blood in the face of extreme systemic hypotension, to reach the brain even with maximal cerebral vasodilation. 12 Thus, autoregulation is not maintained at these low levels, 12,34 but certain physiological criteria of adequate substrate perfusion persistY If the cerebral blood supply is substantially reduced, function is maintained for brief periods by utilization of energy reserves. While the major energy resource for cerebral metabolism is glucose, this and other substrates are usually available in excess, and it is the supply of oxygen that limits aerobic energy production. Thus, protection demonstrated during normotensive anesthesia must to a great extent preserve or reduce requirements of oxygen. Wollman aa suggests that general anesthetics depress cerebral oxygen need as a mechanism for protection. Inhalation anesthetic agents are known to decrease the cerebral metabolic rate of oxygen.
With regard to other potential sources of protection of aerobic metabolism, Nelson and co-workers 23 describe elevation of cerebral glycogen levels in conjunction with normotensive barbiturate and ether anesthesia, indicating increased cerebral levels of glucose, glucose-6-phosphate, and glycogen. Mayman, et al., TM demonstrate during phenobarbital anesthesia that the glucose increase in the brain is too great to be accounted for by a decreased metabolic rate, implying a protective effect of the anesthetic itself with selective mobilization of glucose. Although a mechanism of cerebral protection is indefinite, the combination of an increase in the intracerebral carbohydrate stores with a decrease in the metabolic rate may act as short-term protection for the anesthetized brain.
To assess the postulate that preservation of cerebral metabolism during anesthesia and induced hypotension is due to a relative or absolute increase of cerebral blood flow, Smith, et al., 29 evaluated the effects of cyclopropane on the autoregulation of cerebral blood flow in man, and reported that the cerebral vessels could not dilate sufficiently to maintain an increased flow typical of this agent during normotension. Lassen 12 has shown that cerebral blood flow in man remains remarkably constant over a wide range of fluctuating systemic blood pressures, but as the MAP declines below 60 to 70 mm Hg the flow rapidly declines with cessation of autoregulation. Dogs have been found to have a similar threshold. 34 Lees, et al., ~3 studied regional blood flow in the monkey during halothane anesthesia using radioactive microspheres and found that the brain has a considerable increase in the percentage of systemic flow with both high and low halothane concentrations. Absolute flow to the brain increased 22% with low halothane inhalation but decreased 33% in the high halothane inhalation series, reflecting a large reduction in cardiac output. Wollman and co-workers, e~ studying cerebral circulation with Krypton 85 in humans anesthetized with 1.2% halothane, found this agent to be a mild cerebral vasodilator.
Christensen's group 6,7 also found decreased cerebral vascular resistance with increased cerebral blood flow, concluding that halothane is a cerebral vasodilator. McHenry, et al., ~s reported that 1% halothane lowers cerebral vascular resistance 43%, increasing cerebral blood flow by 64%. McDowall, 17 studying the effect of various concentrations of halothane on blood flow and oxygen uptake by the cerebral cortex, reported that vasodilatory action on cerebral circulation increases with halothane concentration. However, administration of 4% halothane reduces cardiac output markedly so that flow is not elevated above control levels. Preservation of aerobic glycolysis in our experiments is probably not due to known vasodilator effects of halothane because of presumed maximal cerebral vasodilation caused by the profound hypotensive state itself independent of etiology.
The hypothesis that aerobic metabolic processes are primarily preserved as compared to increased substrate flow is reinforced by Brunner, et al., 4 who found that inhalation anesthesia increases energy stores in the mouse brain as much as 1.7-fold. The greatest increases were observed in glucose and glycogen, but glucose-6-phosphate was increased in some cases. The cerebral metabolic rate was depressed by 50%. In our experiments, special attention was paid to maintaining body temperature since Cohen, et al., ~ demonstrated that during halothane anesthesia cerebral oxygen consumption is diminished 15% in the presence of a 1 ~ C fall in body temperature. Alexander, et al., 1 showed that with 70% nitrous oxide and 30% oxygen, cerebral oxygen and glucose consumption are reduced 25 %.
In contrast, Michenfelder, et al., 19-21 demonstrated that cerebral ATP, lactate, and lactate/pyruvate ratios are not altered either by halothane or by the addition of nitrous oxide, thiopental, or hypothermia despite large differences in the effect of these anesthetics or adjuncts on oxygen requirements; their data challenge the notion that anesthetics increase stored high-energy phosphate. Minard and Davis "~2 also reported that anesthetics have no effect on cerebral energy stores in the rat.
We have demonstrated that halothane conveys special protection from ischemia during profound hypotension which is related to the anesthetic state, but the exact mechanism is obscure and may represent a combination of factors.
